Embecta Newsroom

BTIG Maintains Embecta(EMBC.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsDec 10 05:33 ET

BTIG Upgrades Embecta Corporation (EMBC) to a Buy

TipRanksDec 10 05:30 ET

Morgan Stanley Upgrades Embecta to Equalweight, Price Target Is $20

MT NewswiresDec 2 07:48 ET

Embecta Analyst Ratings

BenzingaNov 27 07:33 ET

BTIG Upgrades Embecta to Buy, Announces $26 Price Target

BenzingaNov 27 07:33 ET

Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Maintains Target Price $13

Moomoo NewsNov 27 06:32 ET

BTIG Upgrades Embecta(EMBC.US) to Buy Rating, Announces Target Price $26

Moomoo NewsNov 27 06:31 ET

Embecta Corporation: Discontinued Patch Pump Program and Financial Shortfalls Prompt Sell Rating

TipRanksNov 27 06:18 ET

Embecta Corporation's Strategic Shifts and Revenue Outlook Prompt 'Sell' Rating

TipRanksNov 27 05:50 ET

Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Maintains Target Price $13

Moomoo NewsSep 6 06:31 ET

BTIG Maintains Embecta(EMBC.US) With Hold Rating

Moomoo NewsSep 4 08:33 ET

BTIG Reaffirms Their Hold Rating on Embecta Corporation (EMBC)

TipRanksSep 4 08:22 ET

Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Raises Target Price to $13

Moomoo NewsSep 4 06:31 ET

Recommendation to Sell: Anticipated Costs and Competition Challenge Embecta's New Pump Program

TipRanksSep 4 06:09 ET

Analysts Conflicted on These Healthcare Names: Healthequity (HQY) and Embecta Corporation (EMBC)

TipRanksJul 21 20:17 ET

BTIG Remains a Hold on Embecta Corporation (EMBC)

TipRanksJul 21 20:05 ET

Embecta Analyst Ratings

BenzingaJul 15 13:42 ET

Morgan Stanley Lowers Price Target on Embecta to $12 From $13, Maintains Underweight Rating

MT NewswiresJul 15 06:47 ET

Embecta Analyst Ratings

BenzingaMay 10 11:37 ET

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)

TipRanksApr 1 07:35 ET